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Abstract
Objective
This study aims to analyze the published literatures on the effect of less radical fertility-pre-
serving procedures, such as conization or simple trachelectomy, on oncological outcomes
in IA1 cervical cancer patients with lymphovascular space invasion (LVSI) through a sys-
tematic-review.
Methods
The EMBASE and MEDLINE databases and Cochrane Library were searched for published
studies reporting the oncological outcomes of conization/simple trachelectomy in these
patients, through April 2017. The endpoints were recurrence and mortality rates. Data were
presented as per the Meta-analysis Of Observational Studies in Epidemiology checklist.
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Results
From 6,755 records, 94 full-texts articles were reviewed for eligibility, and five studies were
included in this systematic review. All included studies were nonrandomized studies: two
case-control studies comparing conization (n = 14) with hysterectomy (n = 24), and the
other three were interrupted time series including conization (n = 20) and simple vaginal tra-
chelectomy (n = 59). During the median follow-up duration of 43 months, no recurrence was
reported in both conization and simple trachelectomy groups in IA1 patients with LVSI.
From three studies reporting the fertility outcomes, the rates of pregnancy, live birth, preterm
delivery, and second-trimester miscarriage were 73% (35/48), 64% (32/50), 10% (5/48),
and 6% (3/48), respectively.
Conclusion
Results suggest that simple trachelectomy or conization could be performed for IA1 cervical
cancer patients with LVSI who want to preserve fertility, although these results are only
based on a small number of nonrandomized studies (recommendation grade 2 = weak; evi-
dence level D = very low). Further randomized trials with long-term study period are needed
to address this issue.
Introduction
Cervical cancer is the fourth most common cancer in women; 528,000 new cases were diag-
nosed in 2012 [1]. In Korea, cervical cancer incidence has been decreasing due to effective
screening, with annual percent change of −4.3% recently [2]. The age-standardized incidence
rate is 9.5 per 100,000 persons in 2013 [3]. However, cervical cancer remains to be the most
common gynecologic cancer, and its incidence is still increasing in young women aged<30
years, with annual percent change of +4.8% [4]. Traditionally, a widespread concept that cervi-
cal cancer is not a disease of young women exists. However, according to the 2009–2013 Sur-
veillance, Epidemiology, and End Results data, 38% of cervical cancer cases are diagnosed in
women <45 years old [1]. Similarly, cervical cancer incidence in Korea has increased in
women <35 years old from 2001 to 2011 [5]. With the highlight on the quality of life, preserv-
ing fertility is a crucial issue for the treatment of these reproductive-age patients.
The International Federation of Gynecology and Obstetrics (FIGO) stage IA accounts for
25% of cervical cancers, and 85% of stage IA diseases are stage IA1 [2]. Of note, 50% of patients
with IA cervical cancer are under 40 years old [6]. The diagnosis of stage IA1 can only be estab-
lished via microscopic evaluation of lesion, typically with conization. The depth of stroma
invasion should be<3 mm and the horizontal spread <7 mm. Lymphovascular space invasion
(LVSI) does not change the FIGO staging but should be separately reported because it may
affect treatment strategies. The treatment options for stage IA1 disease are determined based
on the desire of fertility preservation and the LVSI status. The current practice guidelines uni-
formly state therapeutic strategies for IA1 patients who do not desire to preserve fertility: sim-
ple/extrafascial hysterectomy (Type A) is recommended for stage IA1 patients without LVSI,
and modified radical hysterectomy (Type B) and pelvic lymphadenectomy are preferred for
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IA1 patients with LVSI [6–8]. In case of fertility preservation, conization (with negative mar-
gins) is an option in stage IA1 patients without LVSI. Meanwhile, the therapeutic options for
fertility preservation vary according to the guidelines in stage IA1 patients with LVSI; the
NCCN guidelines recommend radical trachelectomy with pelvic lymphadenectomy, and coni-
zation with pelvic lymphadenectomy as the alternative [8]. The ESMO guidelines recommend
conization with pelvic lymphadenectomy [7]. The Japanese Society of Gynecologic Oncology
(JSGO) guidelines do not comment on this issue [6].
All these options have not been compared in randomized clinical trials. In the absence of
level I evidence, the physicians’ personal interpretation of published results might strongly
influence the choice of fertility-preserving procedures. In this study, we review the oncological
and fertility outcomes of less radical fertility-preserving procedures, such as conization or sim-
ple trachelectomy, for the treatment of stage IA1 cervical cancer with LVSI and assess whether
these options show comparable survival outcome compared with radical trachelectomy in
those patients. The Korean Society of Gynecologic Oncology (KSGO) recently revised the
practice guidelines for cervical cancer and selected nine key questions arising in clinical situa-
tions; these questions were derived from thorough discussions with diverse experts in radiol-
ogy, pathology, medical oncology, radiation oncology, and nuclear medicine. This topic is one
of the nine selected key questions.
Materials and methods
Literature search
A systematic review was performed using the designed reporting guidelines (S1 Appendix) [9,
10]. The EMBASE and MEDLINE databases and Cochrane Central Register for Controlled
Trials were searched up to April 2017, irrespective of language. Prepublication papers were
also reviewed. The search strategy is described in the S2 Appendix. Titles and abstracts were
screened to identify relevant articles, and full texts were retrieved for detailed reviews. Refer-
ences in retrieved papers and review articles were manually checked to find additional relevant
studies. Three authors (SS, ML, and HK) independently performed all search.
Eligibility criteria
Inclusion criteria for this systematic review were as follows: (1) randomized controlled trial
(RCT) or prospective or retrospective cohort, nested case control, or population-based case
control study or interrupted time series (ITS) that fulfilled the minimum criteria given by the
Cochrane Effective Practice and Organisation of Care Group (EPOC) [11]; (2) participants
with stage IA1 with LVSI receiving fertility-preserving surgery; (3) conization or simple tra-
chelectomy as the intervention of interest; and (4) outcome measure of recurrence or mortality
rate measured via relative risks, odds ratios, or hazard ratios with 95% confidence intervals (or
sufficient data for calculation). For studies with shared or duplicated data, the most recent or
informative study was selected.
Data extraction
The following data were obtained from eligible studies: name of the authors; publication year;
study design, location, and period; age; sample size, details of fertility-preserving surgery;
tumor characteristics (FIGO stage; tumor size, histology, and LVSI status); follow-up duration;
morbidity related to treatment; oncologic outcomes (recurrence and death from disease); fer-
tility outcomes; and variables controlled for the analysis. Each study was systematically
reviewed for features that might introduce bias, similarity of risk factors for prognosis, and
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PLOS ONE | https://doi.org/10.1371/journal.pone.0189847 January 31, 2018 3 / 13
follow-up in conization/simple trachelectomy groups. Three authors (SS, ML, and HK) inde-
pendently extracted data with the use of a standard extraction sheet; discrepancies were jointly
reviewed until consensus was reached.
Quality assessment
For nonrandomized studies (NRSs), the quality of each study was evaluated using the nine-
star Newcastle–Ottawa Scale (NOS) in three categories: selection, comparability, and exposure
(case-control studies) or outcomes (cohort studies) [12]. A study receiving five or more stars
was defined as high quality [13]. To evaluate the risk of bias for ITS studies, the seven standard
criteria suggested by EPOC are used [14]. Two authors (SS and HK) independently evaluated
the study quality and resolved any disagreement after discussion with all the other authors.
Developing practice guidelines
We made an “evidence profile” for the quality of evidence based on the Grading of Recom-
mendation, Assessment, Development and Evaluation (GRADE) system [15]. The system con-
sidered study qualities, such as consistency, directness of evidence, and the methodologic
quality, to rate an overall quality of the supporting evidence into four categories (A, high; B,
moderate; C, low; D, very low). Finally, we developed the practice guidelines incorporating the
risks and benefits of the compared interventions, provided with the strength of the recommen-
dation (1, strong; 2, weak) and the quality of the supporting evidence (A, high; B, moderate; C,
low; D, very low).
A consensus-building meeting was conducted for the revised guidelines and key questions
by the KSGO Executive Committee on October 2015. The levels of recommendations were
determined by voting by the KSGO members and were passed if 50% or more of the total votes
were in favor. Subsequently, the review and guidelines were presented at the 21st Annual Sym-
posium of KSGO on November 2015.
Results
Literature search
Fig 1 presents a flow diagram of relevant study identification. From 6,755 records, 94 poten-
tially relevant papers were identified, and full texts were reviewed for eligibility. Forty-nine did
not meet the PICO framework. Thirty-three were incomplete studies that provided recur-
rence/mortality data, one showed unsatisfactory follow-up, and six were studies involving
duplicated data used for other studies. These were excluded from further analysis. Five studies
were therefore included in this systematic review [16–20]. S1 Table shows the excluded studies
with reasons for exclusion.
Study characteristics and details
Table 1 lists the detailed study characteristics. Five papers involving 59 IA1 patients with LVSI
undergoing conization or simple trachelectomy and 24 IA1 patients with LVSI undergoing
hysterectomy were published between 2002 and 2014. Studies were conducted in the Nether-
lands [17], Korea [18], US [16], Czech Republic [19], and Canada [20]. All included studies
were nonrandomized observational studies: two were retrospective case-control studies [17,
18], and three were ITS studies [16, 19, 20]. The quality scores for the two case-control studies
were seven on the nine-star NOS (S2 Table). The risk of bias for the three ITS studies are
shown according to the seven standard criteria by EPOC in S3 Table.
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The two case-control studies compared conization (n = 14) with hysterectomy (n = 24). All
included patients had FIGO stage IA1 with LVSI. All the patients with involved resection mar-
gin after the first conization received repeat conization to ensure negative resection margin.
The histologic type was squamous cell only, and lymphadenectomy was not performed in
these studies. During the follow-up period, which was longer than 30 months in these studies,
no recurrence was reported in both conization and hysterectomy groups.
Fig 1. Flow diagram of the literature search procedure.
https://doi.org/10.1371/journal.pone.0189847.g001
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The three ITS studies included conization (n = 20) and simple vaginal trachelectomy
(n = 59). Of the included patients, 18 had FIGO stage IA1 with LVSI, and 51 had IA2 or IB1.
The histologic types were squamous cell (n = 59) or adenocarcinoma (n = 20). All the patients
with involved resection margin after first conization received repeat conization to ensure nega-
tive resection margin. Laparoscopic lymphadenectomy including sentinel lymph node (SLN)
mapping was performed in all ITS studies, and two patients were found to have lymph node
involvement. During the follow-up period, which was longer than 17 months in these studies,
two recurrences were reported. One patient initially received simple trachelectomy for stage
IB1 cervical cancer with LVSI (invasion, 6 mm; diameter, 16 mm; two SLNs with isolated
tumor cells)[20]. This patient was treated with chemoradiation for central recurrence, and no
evidence of disease was noted at the time of publication. The other patient initially received
simple trachelectomy for stage IB1 cervical cancer with LVSI (invasion, 8 mm; diameter, 7
mm; 27 negative nodes)[19]. This patient was treated with chemoradiation therapy for central
recurrence, and no evidence of disease was noted 60 months later. Overall, no recurrence
occurred in patients with IA1 disease.
Three studies reported the fertility outcomes (Table 2)[18–20]. Of those, one reported only
live birth rate of 100% (2 out of 2)[18], and two reported both pregnancy rates and live birth
rates [19, 20]. Rob et al. reported a pregnancy rate of 71% (17 out of 24) and live birth rate of
52% (12 out of 23, 3 pregnancies ongoing at the time of publication)[19]. Meanwhile, Plante
et al. reported a pregnancy rate of 75% (18 out of 24) and live birth rate of 72% (18 out of 25)
[20]. Overall, from three studies reporting the fertility outcomes, the rates of pregnancy, live
birth, preterm delivery, and second-trimester miscarriage were 73% (35/48), 64% (32/50), 10%
(5/48), and 6% (3/48), respectively.
Table 2. Fertility outcomes of studies included in the systematic review.
Study/design Fertility outcomes
Attempting
to
Conceive, n
(%)
Pregnancy
rate, n (%)
Live
birth
rate, n
(%)
Preterm
delivery, n
(%)
First trimester
fetal loss, n
(%)
Second
trimester fetal
loss, n (%)
Bekkers et al. (17)/
Retrospective case-
control study
NR NR NR NR NR NR
Lee et al. (18)/
Retrospective case-
control study
NR NR 2/2 (100) NR NR NR
Plante et al. (20)/
Prospective single arm
cohort study
24/35 (69) 18/24 (75) 18/25
(72)
2/25 (8) 5/25 (20) 0/25 (0)
Andikyan et al. (16)/
Retrospective single
arm cohort study
NR NR NR NR NR NR
Rob et al. (19)/
Retrospective single
arm cohort study
24/32 (75) 17/24 (71) 12/23
(52)
3†/23 (13) 5‡/23 (22) 3/23 (13)
All combined 48/67 (72) 35/48 (73) 32/50
(64)
5/48 (10) 10/48 (21) 3/48 (6)
LVSI, lymphovascular space invasion; NR, not reported
Three pregnancies ongoing at the time of publication.
†In three of these cases, premature delivery occurred (24th, 34th, and 36th weeks).
‡Two women decided on elective abortion for personal reason; one woman was diagnosed with extrauterine
pregnancy; one woman miscarried twice in the first trimester.
https://doi.org/10.1371/journal.pone.0189847.t002
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Developing practice guidelines
In the practice guidelines for cervical cancer recently revised by KSGO [21], the following
question was selected as nine key questions arising in clinical situations: “Does simple trache-
lectomy or conization have similar survival outcome with radical trachelectomy in cervical
cancer stage IA1 patients with LVSI who want to preserve fertility?” The following recommen-
dation was suggested by the KSGO Executive Committee: “Simple trachelectomy or conization
could be performed for cervical cancer IA1 patients with LVSI who want to preserve fertility,
based on the similar survival outcomes from radical trachelectomy (Recommendation grade
2 = weak; Evidence level D = very low).” The “evidence profile” according to the GRADE sys-
tem is shown in S4 Table.
Discussion
In this study, we systematically reviewed oncological outcomes of conization or simple trache-
lectomy in stage IA1 cervical cancer patients with LVSI. Although no study is available to com-
pare conization or simple trachelectomy with radical trachelectomy, the published data so far
reported that no recurrence was observed in those patients after conization or simple trache-
lectomy. Thus, these fertility-preserving procedures could be performed for cervical cancer
IA1 patients with LVSI who want to preserve fertility based on the current systematic review,
albeit the results are based on small number of nonrandomized studies (Recommendation
grade 2 = weak; Evidence level D = very low). Before deciding on fertility preservation, a thor-
ough examination by specialized gynecologic pathologists is essential to accurately evaluate the
histologic type, depth of stromal invasion, and the status of resection margin and LVSI.
Since Daniel Dargent first introduced the vaginal radical trachelectomy and laparoscopic
lymphadenectomy to preserve fertility in patients with cervical cancer in 1986 [22], it has been
the standard fertility-preserving treatment in cases of FIGO stage IA1 with LVSI, IA2, and IB1
with tumor <2 cm [6–8, 23–25]. However, resection of the parametrium and removal of nor-
mal cervical stroma beyond the tumor during radical trachelectomy could compromise fertil-
ity [26]. Indeed, approximately 30% of the pregnancies in women undergoing laparoscopic
radical trachelectomy ended in miscarriage or preterm birth [26, 27]. Moreover, radical tra-
chelectomy may cause adverse surgical outcomes in terms of urologic and neurologic morbidi-
ties [28]. To overcome these caveats of radical trachelectomy, less radical fertility-sparing
approaches without parametrial resection, such as conization or simple trachelectomy, have
been advocated. In 2007, Rob et al. first reported these approaches incorporating two steps
without compromising the oncologic outcome: first, laparoscopic SLN dissection and second,
conization for IA1 with LVSI and IA2 or simple trachelectomy for IB1 with the tumor less
than 2 cm if the SLNs are negative [29]. In their updated published data of 40 enrolled patients,
34 received conization or simple trachelectomy (six with positive SLNs received radical hyster-
ectomy) [19]. During the median follow-up duration of 47 months, only one patient who had
IB1 with LVSI had recurrence, and none of the 13 patients with IA1 with LVSI or IA2 had
recurrence.
Several studies have reported a low risk of parametrial involvement in low-risk early cervi-
cal cancer with favorable clinicopathological variables (i.e., tumor size2 cm, <50% stromal
invasion on MRI, negative LVSI, negative LNM, and depth of stromal invasion <10 mm on
conization) [30–34]. In the review by Ramirez et al., two out of the 247 patients who received
the less radical surgery without parametrial resection for low-risk early cervical cancer had
recurrence [35]. These findings support that less radical surgeries without parametrial resec-
tion are applicable for the selected patients. In the same context, less radical fertility-sparing
surgery, such as conization or simple trachelectomy, can be provided to those patients. It has
Fertility-preservation in IA1 cervical cancer
PLOS ONE | https://doi.org/10.1371/journal.pone.0189847 January 31, 2018 8 / 13
been reported that 26% of young patients with early-stage cervical cancer treated with radical
hysterectomy may have been eligible for fertility-sparing surgery, such as conization [36].
When considering less radical fertility-sparing surgery for IA1 with LVSI, the crucial question
is whether isolated LVSI can be an independent predictor for parametrial involvement in the
absence of other risk factors (i.e., tumor size2 cm, <50% stromal invasion on MRI, negative
lymph node metastasis, and depth of stromal invasion <10 mm on conization). Interestingly,
the published studies so far uniformly reported no parametrial involvement in stage IA1
patients who have LVSI but negative lymph node metastasis [33, 34, 37–39]. Therefore, coniza-
tion or simple trachelectomy can be a reasonable fertility-sparing procedure for IA1 with LVSI
if negative lymph node metastasis is guaranteed.
Of the five studies included in the present systematic review, pelvic lymphadenectomy was
not performed for IA1 with LVSI in two studies [17, 18]. Although no lymph node recurrence
was found during the study period in both the two studies, the number of patients is too small
to support omitting lymphadenectomy in this group. In the other three studies, pelvic lympha-
denectomy including SLN mapping was routinely performed. In the study by Rob et al., six
IB1 patients were excluded for fertility-sparing surgery due to positive lymph node metastasis
after SLN mapping [19]. Current guidelines uniformly recommend performing pelvic lympha-
denectomy in IA1 with LVSI patients [7, 8] because LVSI status has been considered as a sur-
rogate for lymph node metastasis [35]. Ensuring the negative parametrial involvement (as per
the aforementioned rationale) as well as being consistent with those guidelines, we recom-
mend performing lymphadenectomy for IA1 with LVSI. Given the low rate of lymph node
metastasis in this group, SLN mapping can be an option to avoid complete lymphadenectomy
and the related adverse events.
Regarding the fertility outcomes, a pregnancy rate ranged from 71% to 75%, although sec-
ond-trimester miscarriage rate increased compared with the general population (6% vs 1.6%)
[40, 41]. However, those results are still superior to what have been reported after radical tra-
chelectomy [26]. A recent review on various fertility-sparing procedures for cervical cancer
confirmed a higher rate of miscarriage (21% vs 14%) and of preterm delivery (21% vs 12%) for
vaginal radical trachelectomy compared with simple trachelectomy or conization [27]. The
important factor in second-trimester miscarriage or preterm delivery is the amount of residual
cervical stromal tissue after fertility-sparing procedures [42]. In this regard, the fertility out-
comes after conization or simple trachelectomy must be better because these procedures offer
a larger amount of cervical stroma compared with radical trachelectomy. In most series, a cerc-
lage was not routinely performed; however, 24 out of the 35 simple trachelectomy cases in the
study by Plante et al. received the cerclage [20]. Although the rates of second-trimester miscar-
riage and preterm delivery in the study by Plante et al. were lower than those in the simple tra-
chelectomy series by Rob et al., whether routine cerclage would improve the fertility outcomes
remains unclear. Some investigators were concerned that cerclage may negatively affect fertil-
ity due to cervical erosion, stenosis, and chronic vaginal discharges [43]. Thus, consensus for
routine cerclage has not been reached at this point, and we recommend individualized applica-
tion considering the residual cervical length.
The main strength of the present study is its team-based approach to a comprehensive liter-
ature review and a standardized process for reviewing the evidence and generating the guide-
lines. These processes allowed us to summarize all relevant studies and generate helpful
information for both clinicians and patients in decision making for less radical fertility-pre-
serving procedures for IA1 cervical cancer with LVSI.
Our study had also several limitations, and thus the results should be interpreted with cau-
tion. First, all the included studies were NRS. This feature may impede the comprehensive
reporting of any confounding factors. Second, the total number of enrolled cases is small.
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Therefore, the data were insufficient to execute meta-analysis or draw definite conclusions.
Third, the follow-up duration was not long enough to ensure the long-term oncological out-
comes with the weighted mean periods of included studies of 43 months. For these reasons,
the strength of recommendation was determined as weak and the level of evidence as very low
in the practice guidelines for cervical cancer by KSGO [21].
Conclusions
In conclusion, the results suggest that simple trachelectomy or conization could be performed
for cervical cancer IA1 patients with LVSI who want to preserve fertility, although the results
are based on a small number of NRSs subject to a variety of biases. RCTs with a long-term
study period are ideal to address this issue. However, it is likely not feasible to conduct such an
RCT because of the relative rarity and very low rate of recurrence in these patients. Two pro-
spective observational trials are currently underway to assess the effect of conization and pelvic
lymphadenectomy in low-risk early cervical cancer, including IA1 with LVSI [43, 44], and
these trials will provide more solid evidence on the role of this strategy in these patients.
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